
62.19 Delayed Data As of Sep 22 | ![]() Today’s Change | 48.42 Today|||52-Week Range 84.84 | -9.01% Year-to-Date |
Bruker (BRKR) Advances Novel 4D-Proteomics Capabilities Sep 19 / Zacks.com - Paid Partner Content | Bruker (BRKR) Inks Fraport Framework Contract for ETD Systems Sep 12 / Zacks.com - Paid Partner Content |
Previous close | 62.18 |
Today’s open | 62.63 |
Day’s range | 61.97 - 63.04 |
Volume | 43,292 |
Average volume (3 months) | 881,554 |
Market cap | $9.1B |
Earnings growth (last year) | +9.06% |
Earnings growth (this year) | +10.49% |
Earnings growth (next 5 years) | +18.47% |
Revenue growth (last year) | +4.67% |
P/E ratio | 28.8 |
Price/Sales | 4.04 |
Price/Book | 8.21 |
Today’s change | Today’s % change | |
---|---|---|
QGENQiagen NV | -0.19 | -0.48% |
BIOBio Rad Laboratories... | -4.03 | -1.13% |
RVTYRevvity Inc | +1.01 | +0.93% |
---- |
Next reporting date | November 2, 2023 |
EPS forecast (this quarter) | $0.68 |
Annual revenue (last year) | $2.5B |
Annual profit (last year) | $296.6M |
Net profit margin | 11.72% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Billerica, Massachusetts |